Foley Todd

Former 10% Owner at iTeos Therapeutics, Inc. · on record since May 15, 2025
10% owner at Radius Health, Inc. · on record since Nov 22, 2011
Director at Aktis Oncology, Inc. · on record since Jan 14, 2026
10% owner at Aktis Oncology, Inc. · on record since Jan 14, 2026
10% owner at Pacira BioSciences, Inc. · on record since Nov 22, 2011
Director at EPIRUS Biopharmaceuticals, Inc. · on record since Dec 22, 2009
Former 10% stockholder at Verastem, Inc. · on record since Feb 3, 2012
Former 10% Owner at Pacira BioSciences, Inc. · on record since Mar 13, 2013
10% owner at Epizyme, Inc. · on record since May 30, 2013
10% owner at ARATANA THERAPEUTICS, INC. · on record since Jun 26, 2013
10% owner at Histogen Inc. · on record since Jul 24, 2013
Director at Eiger BioPharmaceuticals, Inc. · on record since Jan 29, 2014
10% owner at TriVascular Technologies, Inc. · on record since Apr 23, 2014
Former 10% Owner at Harpoon Therapeutics, Inc. · on record since Apr 15, 2021
Director at CHIASMA, INC · on record since Jul 21, 2015
10% owner at CHIASMA, INC · on record since Jul 21, 2015
10% owner at CHINA ORGANIC FERTILIZER, INC. · on record since Oct 20, 2015
10% owner at Syndax Pharmaceuticals Inc · on record since Mar 9, 2016
Former 10% stockholder at · on record since Sep 29, 2016
Director at · on record since Oct 11, 2017
10% owner at · on record since Oct 11, 2017
10% owner at · on record since Feb 21, 2019
10% owner at · on record since Feb 14, 2019
Director at · on record since Jun 25, 2020
10% owner at · on record since Jun 18, 2020
10% owner at · on record since Jul 29, 2020
10% owner at · on record since Sep 23, 2020
President at · on record since Oct 15, 2020
10% owner at · on record since Oct 8, 2020
10% owner at · on record since Apr 29, 2021
Director at · on record since Oct 28, 2021
10% owner at · on record since Oct 28, 2021

Insider trading activity of Foley Todd

Transactions on record: 183; since Jan 20, 2010

Open-market buys: 7; $25.6M

Open-market sells: 105; $76.9M

Companies traded: 11; last filing Jan 14, 2026

Figures computed from official regulatory filings — .

Companies where Foley Todd has traded

7 tx · $4.2M · Jan 14, 2026
60 tx · $27.1M · Jun 12, 2023
7 tx · $2M · Jun 6, 2022
7 tx · $4M · Oct 12, 2021
18 tx · Aug 5, 2021
56 tx · $65.3M · Mar 16, 2021
8 tx · $250.2K · Mar 11, 2014
7 tx · $1.1M · Feb 6, 2014
6 tx · $2M · Aug 1, 2013
3 tx · $5.5M · Apr 30, 2013
4 tx · May 25, 2012

Track record of Foley Todd

Statistical track record

Free account

Open-market buys: 10

Last buy: Jan 12, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Foley Todd

Co-insiders of Foley Todd

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	716,872	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-2,727,273	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	2,688,270	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-2,272,727	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	597,391	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Buy	232,870	18.00 USD	$4.2M	conv 48ClusterFirst in 12mo	SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-10,227,273	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 12, 2023	AwardD (derivative)	27,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Jun 6, 2022	AwardD (derivative)	11,918	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	May 16, 2022	AwardD (derivative)	49,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	Other	509,024	—	n/a (No price was disclosed in the filing)		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	OtherD (derivative)	-3,683,241	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	Other	3,816,760	—	n/a (No price was disclosed in the filing)		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	Buy	100,000	20.00 USD	$2M	conv 32ClusterFirst in 12mo	SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	OtherD (derivative)	-27,617,675	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 1, 2021	AwardD (derivative)	23,552	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
iTeos Therapeutics, Inc.Listing unverified	Oct 12, 2021	Sell	-48,812	27.24 USD	$1.3M	Unusual size	SEC
iTeos Therapeutics, Inc.Listing unverified	Oct 12, 2021	Sell	-2,032	27.01 USD	$54.9K		SEC
iTeos Therapeutics, Inc.Listing unverified	Oct 12, 2021	Sell	-1,149	27.00 USD	$31K		SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-13,701	27.84 USD	$381.4K		SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-21,253	28.47 USD	$605.1K	Unusual size	SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-10,602	27.03 USD	$286.6K		SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-45,698	28.82 USD	$1.3M	Unusual size	SEC
CHIASMA, INCListing unverified	Aug 5, 2021	OtherD (derivative)	-13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHIASMA, INCListing unverified	Aug 5, 2021	OtherD (derivative)	-13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	716,872	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-2,727,273	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	2,688,270	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-2,272,727	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Other	597,391	—	n/a (No price was disclosed in the filing)		SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	Buy	232,870	18.00 USD	$4.2M	conv 48ClusterFirst in 12mo	SEC
Aktis Oncology, Inc.Listing unverified	Jan 14, 2026	OtherD (derivative)	-10,227,273	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 12, 2023	AwardD (derivative)	27,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Jun 6, 2022	AwardD (derivative)	11,918	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	May 16, 2022	AwardD (derivative)	49,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	Other	509,024	—	n/a (No price was disclosed in the filing)		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	OtherD (derivative)	-3,683,241	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	Other	3,816,760	—	n/a (No price was disclosed in the filing)		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	Buy	100,000	20.00 USD	$2M	conv 32ClusterFirst in 12mo	SEC
Entrada Therapeutics, Inc.Listing on record	Nov 4, 2021	OtherD (derivative)	-27,617,675	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Entrada Therapeutics, Inc.Listing on record	Nov 1, 2021	AwardD (derivative)	23,552	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
iTeos Therapeutics, Inc.Listing unverified	Oct 12, 2021	Sell	-48,812	27.24 USD	$1.3M	Unusual size	SEC
iTeos Therapeutics, Inc.Listing unverified	Oct 12, 2021	Sell	-2,032	27.01 USD	$54.9K		SEC
iTeos Therapeutics, Inc.Listing unverified	Oct 12, 2021	Sell	-1,149	27.00 USD	$31K		SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-13,701	27.84 USD	$381.4K		SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-21,253	28.47 USD	$605.1K	Unusual size	SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-10,602	27.03 USD	$286.6K		SEC
iTeos Therapeutics, Inc.Listing unverified	Sep 20, 2021	Sell	-45,698	28.82 USD	$1.3M	Unusual size	SEC
CHIASMA, INCListing unverified	Aug 5, 2021	OtherD (derivative)	-13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CHIASMA, INCListing unverified	Aug 5, 2021	OtherD (derivative)	-13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC